Doug Cole | search
Click here to view Doug Cole news from 60+ newspapers.
Bookmark or Share- Leadership - VesaliusDoug Cole joined Flagship Pioneering in 2001. He focuses on life science. At Flagship, Doug has co-founded Ensemble Therapeutics, Foghorn Therapeutics (NASDAQ: FHTX), Inzen Therapeutics, Moderna (NASDAQ: MRNA), Permeon Biologics, Sigilon Therapeutics, (NASDAQ: SGTX), and Syros Pharmaceuticals (NASDAQ: SYRS).
- Doug Cole - KSQ Therapeutics - ksqtx.comDoug is a member of the scientific advisory board and the board of directors of the Spinal Muscular Atrophy Foundation. Doug Cole joined Flagship Pioneering in 2001. He focuses on life science.
- Doug Cole - Flagship PioneeringDoug Cole joined Flagship Pioneering in 2001. He focuses on life science. At Flagship, Doug has co-founded Ensemble Therapeutics, Foghorn Therapeutics (NASDAQ: FHTX), Inzen Therapeutics, Moderna (NASDAQ: MRNA), Permeon Biologics, Sigilon Therapeutics, (NASDAQ: SGTX), and Syros Pharmaceuticals (NASDAQ: SYRS).
- Doug Cole - Sana BiotechnologyDouglas Cole, M.D. has served as a member of our Board since April 2020. Dr. Cole joined Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies, in 2001, and is currently a Managing Partner focused on life science investments.
- The Biological Century - Flagship PioneeringDoug Cole. Doug Cole joined Flagship Pioneering in 2001. He focuses on life science. He holds an A.B. magna cum laude with high distinction in English from Dartmouth College, where he was a senior fellow and a member of Phi Beta Kappa, and an M.D. from the…
More
